Could common diabetes and gout drugs ease long COVID? major trial launches
NCT ID NCT07280572
First seen Jan 05, 2026 · Last updated May 24, 2026 · Updated 23 times
Summary
This large Phase 3 trial is testing whether two existing, low-cost medications—metformin and colchicine—can improve physical health and quality of life for people with Long COVID. The study involves 1,250 adults in the Netherlands who have had persistent symptoms like fatigue for at least 12 weeks after a COVID infection. Participation is fully remote, with medications delivered to your home and follow-up via online questionnaires.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST COVID CONDITION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Julius Center for Health Sciences and Primary Care University Medical Center Utrecht, Netherlands
Utrecht, Netherlands
Conditions
Explore the condition pages connected to this study.